Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Cholinesterases: Distribution and Function01:22

Cholinesterases: Distribution and Function

Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.

Science translational medicine·2026
Same author

Structure and dynamics in drug discovery.

npj drug discovery·2026
Same author

The scientific legacy of Martin Karplus from the perspective of his collaborators.

Biophysical journal·2026
Same author

Markovian state models uncover casein kinase 1 dynamics that govern circadian period.

Biophysical journal·2025
Same author

The need to implement FAIR principles in biomolecular simulations.

Nature methods·2025
Same author

Markovian State Models uncover Casein Kinase 1 dynamics that govern circadian period.

bioRxiv : the preprint server for biology·2025

相关实验视频

Updated: Jul 15, 2026

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
06:35

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants

Published on: October 10, 2022

乙胆酶:通过计算分析确定野生类型和H447I突变体的共价抑制机制.

Yuhui Cheng1, Xiaolin Cheng, Zoran Radić

  • 1Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, University of California at San Diego, La Jolla, CA 92093-0365, USA. ycheng@mccammon.ucsd.edu

Journal of the American Chemical Society
|April 28, 2007
PubMed
概括

计算研究揭示了TFK+和TFK0抑制剂与小鼠乙胆化酶 (mAChE) 结合的不同反应机制. H447I突变改变了野生类型的机制,对TFK+和TFK0的水介导催化显示了减少的活性.

相关实验视频

Last Updated: Jul 15, 2026

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
06:35

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants

Published on: October 10, 2022

科学领域:

  • 生物化学 生物化学
  • 计算化学计算化学
  • 酶动力学 酶动力学

背景情况:

  • 鼠标乙胆酶 (mAChE) 是神经传递中的一个关键酶.
  • 了解抑制剂结合机制对于药物开发至关重要.
  • H447I突变显著改变了mAChE活性部位的特性.

研究的目的:

  • 阐明TFK+和TFK0抑制剂与野生型和H447I突变mAChE的反应机制.
  • 为了研究His447在催化机制中的作用.
  • 提供有关TFK0与H447I突变体观察到的活动的机制性见解.

主要方法:

  • 量子力学/分子力学 (QM/MM) 结合的初步方法.
  • 经典分子动力学 (MD) 模拟.
  • 无化学的自由能量计算.

主要成果:

  • 野生型mAChE与TFK+和TFK0的反应是自发的,通过核友添加和质子转移进行.
  • 在H447I突变体中,水分子作为TFK+结合的"充电转载层",Glu334作为催化基.
  • 结合H447I mAChE的TFK0显著较弱,没有发现催化水,导致TFK0几乎不活跃.

结论:

  • H447I突变从根本上改变了mAChE抑制的催化机制.
  • 水分子可以在突变活性位点的酶催化中发挥关键作用.
  • 由于结合和催化机制的改变,TFK0在很大程度上对H447I突变mAChE无效.